Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06697925 · ClinicalTrials.gov registry record
Evaluating the Durability of Closure for Venous Leg Ulcers
A clinical trial of Venous Leg Ulcer and Venous Ulcer, sponsored by Kerecis.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT06697925: Recruiting study of Venous Leg Ulcer and Venous Ulcer, sponsored by Kerecis.
NCT06697925 is a study of Venous Leg Ulcer and Venous Ulcer that is actively recruiting participants, run by Kerecis. The registered enrollment target is 150 participants, below the 241-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06697925, a study of Venous Leg Ulcer and Venous Ulcer, is actively recruiting participants, sponsored by Kerecis.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to determine the durability of closure for venous leg ulcer subjects that achieved closure in the THOR trial.
Primary Outcome
To demonstrate durability of closure (rate of target wound recurrence) of subjects with a closed venous leg ulcer during the THOR clinical trial comparing subjects treated with Intact Fish Skin Graft (IFSG) plus standard of care (SOC) to subjects treated with SOC alone.
Conditions Studied
Study Locations (1)
Pennsylvania
- Serena Group - Monroeville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-01 |
| Est. Completion | 2026-12 |
What NCT06697925 shows while recruiting
NCT06697925 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 241-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (38% lower).
The record links to 5 conditions, with Venous Leg Ulcer appearing as the primary indexed condition, and to 0 interventions.
NCT06697925 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06697925 about?
NCT06697925 is a clinical study titled "Evaluating the Durability of Closure for Venous Leg Ulcers". The goal of this observational study is to determine the durability of closure for venous leg ulcer subjects that achieved closure in the THOR trial.
What is the current status of trial NCT06697925?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-01. Estimated completion is 2026-12.
What conditions does trial NCT06697925 study?
This clinical trial studies the following conditions: Venous Leg Ulcer, Venous Ulcer, Venous Leg Ulcer (VLU), Venous Leg, VLU.
Who is sponsoring clinical trial NCT06697925?
This trial is sponsored by Kerecis, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06697925 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Leg Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06697925's enrollment target sits among peer trials
150 17th of 35 higher than 18 of 35 other Venous Leg Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Venous Leg Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Tissue Repair Gel in Venous Leg Ulcers in AU/US
RECRUITING · Phase 3
-
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
RECRUITING · Phase 4
-
Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia